More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/SARS-CoV-2 (COVID-19) Spike antibody

SARS-CoV-2 (COVID-19) Spike antibody

GTX135356
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Spike antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Sandwich ELISA: . *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.2 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Cheedarla N, Verkerke HP, Potlapalli S, et al. Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers. iScience. 2023,26(11):108256. doi: 10.1016/j.isci.2023.108256
    Read this paper
  • Park SB, Khan M, Chiliveri SC, et al. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Commun Biol. 2023,6(1):556. doi: 10.1038/s42003-023-04923-x
    Read this paper
  • Gao SY, Amaro-Mugridge NB, Madrid-Weiss J, et al. Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern. Front Immunol. 2022,13:1038562. doi: 10.3389/fimmu.2022.1038562
    Read this paper
  • Merino VF, Yan Y, Ordonez AA, et al. Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells. Antiviral Res. 2023,211:105550. doi: 10.1016/j.antiviral.2023.105550
    Read this paper
  • Imanishi I, Asahina R, Hayashi S, et al. Guest edited collection serological study of SARS-CoV-2 antibodies in japanese cats using protein-A/G-based ELISA. BMC Vet Res. 2022,18(1):443. doi: 10.1186/s12917-022-03527-7
    Read this paper
  • Arai Y, Yamanaka I, Okamoto T, et al. Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists. iScience. 2023,26(1):105742. doi: 10.1016/j.isci.2022.105742
    Read this paper
  • Ishigaki H, Yasui F, Nakayama M, et al. An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants. Front Microbiol. 2022,13:967019. doi: 10.3389/fmicb.2022.967019
    Read this paper
  • Hayashi H, Sun J, Yanagida Y, et al. Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant. Sci Rep. 2022,12(1):20923. doi: 10.1038/s41598-022-24519-5
    Read this paper
  • Ruiz MJ, Siracusano G, Cottignies-Calamarte A, et al. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis. Front Immunol. 2022,13:842468. doi: 10.3389/fimmu.2022.842468
    Read this paper
  • Kumar CS, Singh B, Rizvi ZA, et al. Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells. ACS Infect Dis. 2022,8(10):2119-2132. doi: 10.1021/acsinfecdis.2c00217
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions